About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 48 record(s)
Req # A-2023-00027
(a) Any copies of any application, including the underlying evidence to support such application, made by the Insurance Company of North America to the Superintendent of Financial Institutions to release its Canadian assets between 1992 and 1993, particularly in respect of its insurance policies being transferred, surrendered, reinsured, or discharged. (d) Any copies of an order made by the Superintendent of Financial Institutions in respect of the Insurance Company of North America’s assets in Canada being released between 1992 and 1993, particularly in respect of its insurance policies being transferred, surrendered, reinsured. (e) Any documents or correspondence in respect of the Insurance Company of North America’s Canadian liabilities being transferred to CIGNA Insurance Company of Canada and/or in respect of its insurance policies being transferred, surrendered, reinsured, or discharged generally prior to 1994. (f) Any documents or correspondence in respect of the Insurance Company of North America’s ceasing to be registered as an insurer, effective February 28, 1993Organization: Office of the Superintendent of Financial Institutions Canada
February 2024
Req # A-2024-54596
Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://www.canada.ca/en/patented-medicine-prices-review/services/consultations/scoping-paper-board-guidelines.htmlOrganization: Patented Medicine Prices Review Board Canada
February 2024
Req # A-2023-00002
Materials relating to OSFI/BSIF - 22-23-SIF-EA-8088 - Various Position / Divers postes (RE-05) including but not limited to: How the competencies were created and established in relation OSFI/BSIF - 22-23-SIF-EA-8088 including research, development and decisions made to these competencies. How many applicants applied to OSFI/BSIF - 22-23-SIF-EA-8088 and how many made it to each stage of the competition such as written test, interview and background check stages. How the written test was created, what decisions, research and evidence went into the creation of the written test for OSFI/BSIF - 22-23-SIF-EA-8088. How the interview questions were created what decisions, research and evidence went into the creation of the oral interview for OSFI/BSIF - 22-23-SIF-EA-8088. Information about when, how and where the hiring manager and/or hiring panel meet to discuss any of above and below points including handwritten notes, briefing notes, presentations, research, calendar invitations and appointments. Information about the hiring panel excluding personnel information about how many people and what position they occupy in relation to OSFI/BSIF - 22-23-SIF-EA-8088. Any scoring methodologies, rubrics as related to written testing and interviews associated with OSFI/BSIF - 22-23-SIF-EA-8088. In addition to information that relates to how such scoring methodologies, rubrics are created from research, evidence and decision documents. Email templates or other communication templates that are used to inform applicants during all stages of the competition. All documents associated with approval of OSFI/BSIF - 22-23-SIF-EA-8088. All documents associated with the development of the online advertisement of OSFI/BSIF - 22-23-SIF-EA-8088.Organization: Office of the Superintendent of Financial Institutions Canada
June 2023
Req # A-2023-00006
Power point presentation for the timeline and deadline of the finsight 1.0 and finsight 2.0 migration to cloudOrganization: Office of the Superintendent of Financial Institutions Canada
June 2023
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09063
Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09228
All correspondence between PMPRB Board members and PMPRB staff pertaining to the October 2022 revised draft Guidelines and the resignation of the PMPRB Acting Chairperson, Mélanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09229
All correspondence between the former PMPRB Acting Chairperson, Melanie Bourassa-Forcier, and the Minister of Health Jean-Yves Duclos (including the Minister’s staff), or Deputy Minister of Health Stephen Lucas (including the Deputy Minister’s staff), about the PMPRB October 2022 revised draft Guidelines and the resignation of PMPRB Acting Chairperson, Melanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09230
All correspondence between PMPRB Executive Director Doug Clark and the Minister of Health Jean-Yves Duclos (including the Minister’s staff), or Deputy Minister of Health Stephen Lucas (including the Deputy Minister’s staff), about the PMPRB October 2022 revised draft Guidelines and the resignation of PMPRB Acting Chairperson, Melanie Bourassa-Forcier. “Correspondence” includes written correspondence, call notes, email, text messaging, instant messaging, and any other form of electronic communication.Organization: Patented Medicine Prices Review Board Canada
February 2023